Sofinnova Investments, Inc. Quant / Systematic

Location: Menlo Park, CA

CIK: 0001631134 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $1.68B (100.0% shares, 0.0% debt)

Holdings (68)

NTRA Natera 18.4%
Value $309M Shares 3,100,560 Est. Cost $9.81 Unrealized +751.8%
Karuna Therapeutics, Inc. 11.8%
Value $198M Shares 1,952,441 Est. Cost $26.41 Unrealized
ASND Ascendis Pharma A/S 11.0%
Value $185M Shares 1,109,874 Est. Cost $69.98 Unrealized
Y-mAbs Therapeutics, Inc 6.5%
Value $109M Shares 2,194,278 Est. Cost $26.75 Unrealized
UTHR United Therapeutics Corp 3.1%
Value $52.81M Shares 347,901 Est. Cost $94.24 Unrealized +39.3%
Checkmate Pharmaceuticals Inc 3.1%
Value $52.62M Shares 3,606,707 Est. Cost $11.51 Unrealized
AZN AstraZeneca PLC 2.5%
Value $42.12M Shares 842,600 Est. Cost $49.99 Unrealized
Inozyme Pharma, Inc. 2.5%
Value $41.86M Shares 2,028,308 Est. Cost $26.29 Unrealized
AMGN Amgen Inc 2.3%
Value $37.86M Shares 164,663 Est. Cost $205.28 Unrealized -4.4%
JAZZ Jazz Pharmaceuticals PLC 2.1%
Value $35.14M Shares 212,911 Est. Cost $125.47 Unrealized +18.7%
XLV Health Care Select Sector SPDR 2.0%
Value $34.03M Shares 300,000 Est. Cost Unrealized
GRTX Galera Therapeutics, Inc 1.9%
Value $31.55M Shares 3,083,712 Est. Cost $12.19 Unrealized -10.3%
ABBV Abbvie Inc 1.9%
Value $31.46M Shares 293,596 Est. Cost $71.54 Unrealized +10.3%
Akouos, Inc 1.8%
Value $30.04M Shares 1,515,074 Est. Cost $22.50 Unrealized
Nextcure, Inc 1.7%
Value $29.12M Shares 2,671,856 Est. Cost $10.90 Unrealized
Intra-Cellular Therapies Inc 1.6%
Value $26.97M Shares 848,162 Est. Cost $27.53 Unrealized
IWM iShares Russell 2000 ETF 1.5%
Value $25.49M Shares 130,000 Est. Cost Unrealized
Nucana Biomed Ltd 1.5%
Value $25.14M Shares 5,599,999 Est. Cost $9.47 Unrealized
Merus N.V. 1.4%
Value $22.98M Shares 1,311,039 Est. Cost $18.53 Unrealized
PTCT PTC Therapeutics Inc 1.1%
Value $19.32M Shares 316,478 Est. Cost $43.59 Unrealized +35.2%
Reata Pharmaceuticals Inc 1.1%
Value $18.41M Shares 148,937 Est. Cost $116.68 Unrealized
Athira Pharma, Inc. 1.0%
Value $17.44M Shares 509,168 Est. Cost $18.46 Unrealized
Otonomy Inc 1.0%
Value $16.96M Shares 2,620,668 Est. Cost $3.81 Unrealized
Horizon Therapeutics PLC 0.9%
Value $15.61M Shares 213,390 Est. Cost $73.15 Unrealized
Protagonist Therapeutics Inc 0.9%
Value $14.61M Shares 724,904 Est. Cost $20.16 Unrealized
BMRN Biomarin Pharmaceutical Inc 0.9%
Value $14.43M Shares 164,545 Est. Cost $95.51 Unrealized -17.0%
ACRS Aclaris Therapeutics 0.7%
Value $12.37M Shares 1,911,573 Est. Cost $19.07 Unrealized -77.9%
RGNX Regenxbio Inc 0.7%
Value $12.3M Shares 271,114 Est. Cost $34.43 Unrealized +1.5%
GW Pharmaceuticals PLC 0.7%
Value $11.63M Shares 100,762 Est. Cost $100.55 Unrealized
Nucana Biomed Ltd 0.6%
Value $10.78M Shares 2,400,000 Est. Cost $5.41 Unrealized
CYTK Cytokinetics Inc 0.6%
Value $10.56M Shares 508,394 Est. Cost $20.33 Unrealized -10.1%
MGNX MacroGenics Inc 0.6%
Value $10.49M Shares 458,807 Est. Cost $23.02 Unrealized 0.0%
TCR2 Therapeutics Inc 0.6%
Value $10.32M Shares 333,707 Est. Cost $25.43 Unrealized
INSM Insmed Inc 0.6%
Value $10.31M Shares 309,662 Est. Cost $24.78 Unrealized +47.4%
ObsEva SA 0.6%
Value $9.879M Shares 4,749,623 Est. Cost $13.49 Unrealized
Arena Pharmaceuticals Inc 0.6%
Value $9.325M Shares 121,373 Est. Cost $73.99 Unrealized
SRPT Sarepta Therapeutics Inc 0.5%
Value $8.84M Shares 51,848 Est. Cost $148.17 Unrealized 0.0%
ACAD ACADIA Pharmaceuticals Inc 0.5%
Value $8.801M Shares 164,625 Est. Cost $47.72 Unrealized +4.0%
BCRX BioCryst Pharmaceuticals Inc 0.5%
Value $8.365M Shares 1,122,800 Est. Cost $4.01 Unrealized +28.5%
SNDX Syndax Pharmaceuticals Inc 0.5%
Value $8.293M Shares 372,909 Est. Cost $20.74 Unrealized 0.0%
MIRM Mirum Pharmaceuticals Inc 0.5%
Value $7.944M Shares 454,974 Est. Cost $17.41 Unrealized +12.9%
CHRS Coherus BioSciences 0.4%
Value $7.553M Shares 434,555 Est. Cost $10.94 Unrealized +62.7%
ChemoCentryx Inc 0.4%
Value $7.01M Shares 113,213 Est. Cost $49.89 Unrealized
Jounce Therapeutics Inc 0.4%
Value $6.477M Shares 925,280 Est. Cost $7.00 Unrealized
PBYI Puma Biotechnology Inc 0.4%
Value $6.46M Shares 629,650 Est. Cost $10.04 Unrealized +0.9%
LLY Eli Lilly and Co 0.4%
Value $6.232M Shares 36,909 Est. Cost $143.90 Unrealized -1.8%
Amarin Corp 0.3%
Value $5.724M Shares 1,170,584 Est. Cost $7.81 Unrealized
Aligos Therapeutics Inc 0.3%
Value $5.283M Shares 191,061 Est. Cost $27.65 Unrealized
RCUS Arcus Biosciences Inc 0.3%
Value $4.836M Shares 186,278 Est. Cost $24.20 Unrealized 0.0%
Acceleron Pharma Inc 0.3%
Value $4.694M Shares 36,688 Est. Cost $57.73 Unrealized
IOVA Iovance Biotherapeutics Inc 0.3%
Value $4.64M Shares 100,000 Est. Cost Unrealized
Aptose Biosciences Inc 0.3%
Value $4.297M Shares 981,135 Est. Cost $4.38 Unrealized
IGM Biosciences Inc 0.2%
Value $3.985M Shares 45,131 Est. Cost $88.30 Unrealized
KURA Kura Oncology Inc 0.2%
Value $3.941M Shares 120,677 Est. Cost $14.42 Unrealized +143.6%
TGTX TG Therapeutics Inc 0.2%
Value $3.406M Shares 65,474 Est. Cost $12.49 Unrealized +170.5%
Marinus Pharmaceuticals Inc 0.2%
Value $3.343M Shares 274,027 Est. Cost $12.20 Unrealized
IMTX Immatics NV 0.2%
Value $3.016M Shares 279,532 Est. Cost $10.53 Unrealized +0.1%
Calithera Biosciences Inc 0.1%
Value $2.457M Shares 500,326 Est. Cost $4.49 Unrealized
Calithera Biosciences Inc 0.1%
Value $1.964M Shares 400,000 Est. Cost $4.49 Unrealized
Zogenix Inc 0.1%
Value $1.791M Shares 89,579 Est. Cost $19.99 Unrealized
Synlogic Inc. 0.1%
Value $1.242M Shares 574,972 Est. Cost $9.38 Unrealized
FATE Fate Therapeutics Inc 0.1%
Value $1.227M Shares 13,497 Est. Cost $34.92 Unrealized +77.9%
Kadmon Holdings Inc 0.1%
Value $950K Shares 228,893 Est. Cost $2.74 Unrealized
Calithera Biosciences Inc 0.1%
Value $860K Shares 175,000 Est. Cost $4.49 Unrealized
REPL Replimune Group Inc 0.0%
Value $763K Shares 20,000 Est. Cost $41.67 Unrealized 0.0%
LQDA Liquidia Corp 0.0%
Value $436K Shares 147,744 Est. Cost $7.59 Unrealized -51.6%
PDSB PDS Biotechnology Corporation 0.0%
Value $305K Shares 142,635 Est. Cost $8.36 Unrealized -73.8%
BCAB Bioatla Inc 0.0%
Value $102K Shares 3,000 Est. Cost $33.43 Unrealized 0.0%